New conjugates based on N4-hydroxycytidine with more potent antiviral efficacy in vitro than EIDD-2801 against SARS-CoV-2 and other human coronaviruses
Article in Antiviral Research (March 2024)
The most recent citing publications are shown below. View all 48 publications that cite this research output on Dimensions.
Structure and Ligand-based In Silico Studies towards the Natural Inhibitors against Receptor Recognition Spike Protein of SARS-CoV-2
Article in The Open Bioinformatics Journal (March 2024)
Chapter 10 Potential therapeutic landscape of COVID-19: molecular targets, repurposed drugs, and nano- and cell-based intervention
Book chapter (January 2024)